Cyclooxygenase-2 in human pathological disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4615-0193-0_28PMID 12664583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy.

  1999cited by this paper
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis

  1999cited by this paper
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.

  1998cited by this paper
• Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Cyclooxygenase in biology and disease

  1998cited by this paper
• Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Prostaglandin synthase 2.

  1996cited by this paper
• Nonsteroidal antiinflammatory drugs and breast cancer.

  1996cited by this paper
• Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.

  1996cited by this paper
• Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract.

  1996cited by this paper
• Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer.

  1995cited by this paper
• Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study

  1994cited by this paper
• Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

  1994cited by this paper
• Aspirin use and risk of fatal cancer.

  1993cited by this paper

• The Role of Tumor-Intrinsic HuR in Modeling the Pancreatic Tumor Microenvironment: Molecular Mechanisms and Therapeutic Opportunities

  2025cites this paper
• RUNX1-induced upregulation of PTGS2 enhances cell growth, migration and invasion in colorectal cancer cells

  2024cites this paper
• Activity-dependent COX-2 proteolysis generates a catalytically inactive fragment that affects aerobic respiration and proliferation

  2024cites this paper
• Activity-dependent COX-2 proteolysis modulates aerobic respiration and proliferation in a prostaglandin-independent manner

  2024cites this paper
• Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer

  2023cites this paper
• Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer

  2023cites this paper
• Protective effects of hesperidine against organ toxicity and oxidative stress induced by piroxicam in wistar rats

  2023cites this paper
• Fabrication of wheatgrass incorporated PCL/chitosan biomimetic nanoscaffold for skin wound healing: In vitro and In silico analysis

  2022cites this paper
• Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes

  2022cites this paper
• A Research Article Submitted to Journal of Ethnopharmacology Naoxintong restores Ischemia Injury and inhibits Thrombosis via COX2-VEGF/ NFκB Signaling.

  2021cites this paper
• Neoplastic Disease

  2021cites this paper
• Study of Diagnostic Value of Cyclooxygenase-2 and Matrix Metalloproteinases in Atherosclerosis

  2021cites this paper
• Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya

  2021cites this paper
• A Comparative study on the protective role of Silymarin and Coenzyme-Q10 on the cerebellar cortex of experimentally induced atherosclerosis in adult male albino rats: A Histological, Immunohistochemical and Biochemical study

  2020cites this paper
• Polyphenols’ Role in Autoimmune and Chronic Inflammatory Diseases and the Advent of Computer-Driven Plant Therapies

  2020cites this paper
• Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly-mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair.

  2019cites this paper
• Predicting significance of COX-2 expression of peripheral blood monocyte in patients with coronary artery disease.

  2019cites this paper
• Hydroxytyrosol Modulates Adipocyte Gene and miRNA Expression Under Inflammatory Condition

  2019cites this paper
• Cardio-renal safety of non-steroidal anti-inflammatory drugs.

  2019cites this paper
• Risk of Cancer in the Digestive System in Adult Obese Norwegians: An Unselected Population-Based Study

  2019cites this paper
• The integration of inflammaging in age-related diseases.

  2018cites this paper
• Study of the anti(myco)bacterial and antitumor activities of prolinate and N-amidocarbothiolprolinate derivatives based on fused tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione, bearing an indole ring

  2018cites this paper
• Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism.

  2017cites this paper
• The anticancer and antiobesity effects of Mediterranean diet

  2017cites this paper
• Cox-2 inhibition potentiates mouse bone marrow stem cell engraftment and differentiation-mediated wound repair.

  2017cites this paper
• Atherosclerosis and Disc Degeneration: A Cross-Sectional Study

  2016cites this paper
• A Review on Pyridazinone Compounds ABT-963 as Selective CyclooxygenaseInhibitor

  2016cites this paper
• Link of obesity and gastrointestinal cancer: crossroad of inflammation and oxidative stress.

  2015cites this paper
• Association of Severe Disc Degeneration With All‐Cause Mortality and Abdominal Aortic Calcification Assessed Prospectively in Older Men: Findings of a Single‐Center Prospective Study of Osteoporosis in Men

  2015cites this paper
• Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review.

  2015cites this paper
• Obesity, Diabetes and Cancer: A Mechanistic Perspective.

  2015cites this paper
• Epigenetic linkage of aging, cancer and nutrition

  2015cites this paper
• The relationship between obesity and cancer

  2015cites this paper
• Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases

  2015cites this paper
• Senescence-associated inflammatory responses: aging and cancer perspectives.

  2015cites this paper
• Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet.

  2015cites this paper
• Ameliorative Effect of Pimpinella anisum Oil on Immunohistochemical and Ultrastuctural Changes of Cerebellum of Albino Rats Induced by Aspartame

  2014cites this paper
• Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

  2014cites this paper
• Interacting inflammatory and growth factor signals underlie the obesity-cancer link.

  2014cites this paper
• Biology of Human Tumors Inhibition of Tumor-Derived Prostaglandin-E 2 Blocks the Induction ofMyeloid-DerivedSuppressorCells andRecovers Natural Killer Cell Activity

  2014cites this paper
• COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks

  2014influential citation
• Obesity, energy balance, and cancer: a mechanistic perspective.

  2014cites this paper
• Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways

  2014cites this paper
• Urinary PGE-M: A Promising Cancer Biomarker

  2013cites this paper
• Mechanistic Targets and Phytochemical Strategies for Breaking the Obesity-Cancer Link

  2013cites this paper
• Homocysteine induces COX-2 expression in macrophages through ROS generated by NMDA receptor-calcium signaling pathways

  2013cites this paper
• Calorie restriction and cancer prevention: a mechanistic perspective

  2013cites this paper
• Anti-inflammatory effects of essential oils from Chamaecyparis obtusa via the cyclooxygenase-2 pathway in rats.

  2013cites this paper
• The circadian clock in cancer development and therapy.

  2013cites this paper
• Calorie Restriction and Cancer Prevention: Established and Emerging Mechanisms

  2013cites this paper
• Metabolic Perturbations Associated with Adipose Tissue Dysfunction and the Obesity–Cancer Link

  2013cites this paper
• Evaluation of Food-derived Functional Ingredients According to Activation of PPAR and Suppression of COX-2 Expression

  2013cites this paper
• Growth Signals, Inflammation, and Vascular Perturbations: Mechanistic Links Between Obesity, Metabolic Syndrome, and Cancer

  2012cites this paper
• Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development

  2012cites this paper
• ATVB in Focus Metabolic Syndrome and Insulin Resistance: Mechanisms and Consequences

  2012cites this paper
• Quantitative assessment of abdominal aortic calcification and associations with lumbar intervertebral disc height loss: the Framingham Study.

  2012cites this paper
• Immunomodulation by Stemona tuberosa ethanol extract in vitro and in ovalbumin-induced mouse asthma model

  2012cites this paper
• Intramuscular inoculation of cattle with Sarcocystis antigen results in focal eosinophilic myositis.

  2012cites this paper
• Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma

  2012cites this paper
• EVALUATION OF CYCLOOXYGENASE PROTEIN EXPRESSION IN TRAUMATIZED VERSUS NORMAL TISSUES FROM EASTERN BOX TURTLES (TERRAPENE CAROLINA CAROLINA)

  2012cites this paper
• Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk

  2012cites this paper
• A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats

  2012cites this paper
• The growing challenge of obesity and cancer: an inflammatory issue

  2011cites this paper
• Defects in mouse nephrogenesis induced by selective and non‐selective cyclooxygenase‐2 inhibitors

  2011cites this paper
• Effects of 4-Hydroxy-2-Nonenal, a Major Lipid Peroxidation-Derived Aldehyde, and N-Acetylcysteine on the Cyclooxygenase-2 Expression in Human Uterine Myometrium

  2011cites this paper
• The prognostic value of c‐Kit, K‐ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer

  2010cites this paper
• Citral, a component of lemongrass oil, activates PPARα and γ and suppresses COX-2 expression.

  2010cites this paper
• Prostanoids and colorectal cancer

  2010cites this paper
• The peroxisome proliferator-activated receptors (PPARs) are members of a nuclear receptor family of li-

  2010cites this paper
• NF-κB 활성 저해를 통한 협죽도 에탄올 추출물의 항염증 효능

  2010cites this paper
• Pathophysiology of Cyclooxygenases in Cardiovascular Homeostasis

  2010cites this paper
• Pharmacotherapy of cancer pain in dogs and cats suffering from cancer.

  2010cites this paper
• Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules.

  2010cites this paper
• The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway

  2010cites this paper
• Anti-Inflammmatiry Effects of Nerium indicum Ethanol Extracts through Suppression of NF-kappaB Activation

  2010cites this paper
• Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients.

  2010cites this paper
• Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non‐small cell lung cancer cells

  2009cites this paper
• The Journal of Toxicological Sciences

  2009cites this paper
• Expression and activity of COX‐1 and 2 and 5‐LOX in joint tissues from dogs with naturally occurring coxofemoral joint osteoarthritis

  2009cites this paper
• Clinical Study Prognostic Significance and Clinicopathological Associations of Cox-2 Snp in Patients with Nonsmall Cell Lung Cancer

  2009cites this paper
• Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer

  2009influential citation
• A critical role of COX-2 in the progression of neointimal formation after wire injury in mice

  2009cites this paper
• Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?

  2008cites this paper
• Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy

  2008cites this paper
• A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress.

  2008cites this paper
• Identification of a Serum Component That Regulates Cyclooxygenase-2 Gene Expression in Cooperation with 4-Hydroxy-2-nonenal*

  2007cites this paper
• Functional Polymorphisms in the Cyclooxygenase 2 (COX-2) Gene and Risk of Breast Cancer in a Chinese Population

  2007cites this paper
• Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model

  2007cites this paper
• Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells.

  2007cites this paper
• Effects of selective and non‐selective cyclo‐oxygenase inhibition on endothelial function in patients with rheumatoid arthritis

  2007cites this paper
• Targeted therapies for non-small cell lung cancer.

  2007cites this paper
• Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt

  2007cites this paper
• Down-Regulation of PGE2 by Physiologic Levels of Celecoxib is not Sufficient to Induce Apoptosis or Inhibit Cell Proliferation in Human Colon Carcinoma Cell Lines

  2007cites this paper
• Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling.

  2006cites this paper
• Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in human renal allograft rejection – a prospective study

  2006cites this paper
• The COX-2 G/C −765 polymorphism may modulate the occurrence of cerebrovascular ischemia

  2006cites this paper
• Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises.

  2006cites this paper
• Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

  2006cites this paper
• Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever

  2006cites this paper
• A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats.

  2006cites this paper